ClinicalTrials.gg

DICE Therapeutics, Inc. clinical trials

Acquired by Eli Lilly and Company, Aug 9, 2023 · source ↗

The registry lists 10 studies whose lead sponsor is DICE Therapeutics, Inc. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 19, 2026.

Before and after it joined Eli Lilly and Company

First submitted before DICE Therapeutics, Inc. became part of Eli Lilly and Company
1
First submitted after DICE Therapeutics, Inc. became part of Eli Lilly and Company
8
Unclear, or no submission date
1

By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.

What it is testing

The drugs DICE Therapeutics, Inc.’s studies test, most studies first; none is open now — 4 drugs with a page of their own. Each count opens the studies in search.

Studies, none open

All 10 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Completed10100%

Phase

  • Phase 18
  • Phase 22

Where

  • United States8
  • Poland2
  • Canada2
  • Czechia2
  • Hungary2
  • Germany2

Over the years

  1. 21
  2. 22
  3. 23
  4. 524
  5. 25
  6. 026

By the year each study started. 2026 so far in the lighter column.

Registry sponsor names on this page

  • DICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company10 studies

Something wrong with this grouping? Tell us on the Eli Lilly and Company page.

Studies

Recruiting first, then most recently updated. Showing 10 of 10. All Eli Lilly and Company studies →